COVID-19 in cancer patients-Reference-Cited by-同舟云学术

COVID-19 in cancer patients

Published:2022-03-11 Issue:9 Volume:116 Page:767-797
ISSN:0035-9203
Container-title:Transactions of The Royal Society of Tropical Medicine and Hygiene
language:en
Short-container-title:

Author:

Seneviratne Suranjith L¹²,Wijerathne Widuranga³,Yasawardene Pamodh³,Somawardana Buddhika⁴

Affiliation:

1. Institute of Immunity and Transplantation, Royal Free Hospital and University College London , UK

2. Nawaloka Hospital Research and Education Foundation, Nawaloka Hospitals , Colombo, Sri Lanka

3. Faculty of Medicine, University of Colombo , Sri Lanka

4. National Cancer Institute , Maharagama, Sri Lanka

Abstract

Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2, has currently affected >220 million individuals worldwide. The complex interplay of immune dysfunction, active malignancy, the effect of cancer treatment on the immune system and additional comorbidities associated with cancer and COVID-19 all affect the outcomes of COVID-19 in patients with cancer. We have discussed the published findings (through the end of September 2021) on the effects of cancer on the morbidity and mortality of COVID-19, common factors between cancer and COVID-19, the interaction of cancer and COVID-19 treatments, the impact of COVID-19 on cancer clinical services, immune test findings in cancer patients with COVID-19 and the long-term effects of COVID-19 on cancer survivors.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Medicine,Parasitology

Link

https://academic.oup.com/trstmh/article-pdf/116/9/767/45788043/trac015.pdf

Reference183 articles.

1. Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak;Dai;Cancer Discov,2020

2. Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium;Grivas;Ann Oncol,2021

3. Clinical portrait of the SARS-CoV-2 epidemic in European patients with cancer;Pinato;Cancer Discov,2020

4. Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study;Tian;Lancet Oncol,2020

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of cancer metastases on COVID‐19 outcomes: A COVID‐19 and Cancer Consortium registry‐based retrospective cohort study;Cancer;2024-02-20

2. COVID-19 in cancer patients: patient characteristics and outcomes in the post-COVID-19 vaccination period;Turkish Journal of Medical Sciences;2023-12-12

3. COVID‐19 and cancer: Dichotomy of the menacing dilemma;MedComm – Oncology;2023-11-30

4. Anti-bladder cancer and COVID-19 potentials of pachymic acid: clinical features and therapeutic targets;International Journal of Food Properties;2023-09-05

5. Cancer management during the COVID-19 world pandemic;Cancer Immunology, Immunotherapy;2023-08-29